RealSeq

RealSeq Biosciences is changing the way diseases are detected with its RNA fragmentomics technology. Their RiboMarker® platform analyzes RNA fragments that traditional methods often miss, giving a fuller picture of the transcriptome. By capturing 90% of the RNA in a sample, compared to the 10% captured by regular RNA sequencing, RealSeq offers more detailed insights into disease progression, including its stage and changes over time. This technology is set to improve diagnostics in fields like cancer, infectious diseases, and agriculture.